MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12981-019-0241-3

Медицинская библиотека · AIDS research and therapy · 2019

Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004-2017).

Aliyu Ahmad, Adelekan Babatunde, Andrew Nifarta, Ekong Eunice, Dapiap Stephen, Murtala-Ibrahim Fati, Nta Iboro, Ndembi Nicaise, Mensah Charles, Dakum Patrick

СтатьяПоддержка правительства СШАПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

Expanded access to antiretroviral therapy (ART) leads to improved HIV/AIDS treatment outcomes in Nigeria, however, increasing rates of loss to follow-up among those on ART is threatening optimal standard achievement. Therefore, this retrospective cross-sectional study is aimed at identifying correlates and predictors of loss to follow-up in patients commencing ART in a large HIV program in Nigeria.

METHODS

Records of all patients from 432 US CDC Presidents Emergency Plan for AIDS Relief (PEPFAR) supported facilities across 10 States and FCT who started ART from 2004 to 2017 were used for this study. Bivariate and multivariate analysis of the demographic and clinical parameters of all patients was conducted using STATA version 14 to determine correlates and predictors of loss to follow-up.

RESULTS

Within the review period, 245,257 patients were ever enrolled on anti-retroviral therapy. 150,191 (61.2%) remained on treatment, 10,960 (4.5%) were transferred out to other facilities, 6926 (2.8%) died, 2139 (0.9%) self-terminated treatment and 75,041 (30.6%) had a loss to follow-up event captured. Males (OR: 1.16), Non-pregnant female (OR: 4.55), Patients on ≥ 3-monthly ARV refills (OR: 1.32), Patients with un-suppressed viral loads on ART (OR: 4.52), patients on adult 2nd line regimen (OR: 1.23) or pediatric on 1st line regimen (OR: 1.70) were significantly more likely to be lost to follow-up.

CONCLUSION

Despite increasing access to anti-retroviral therapy, loss to follow-up is still a challenge in the HIV program in Nigeria. Differentiated care approaches that will focus on males, non-pregnant females and paediatrics is encouraged. Reducing months of Anti-retroviral drug refill to less than 3 months is advocated for increased patient adherence.

Для цитирования: Aliyu Ahmad, Adelekan Babatunde, Andrew Nifarta, Ekong Eunice, Dapiap Stephen, Murtala-Ibrahim Fati, Nta Iboro, Ndembi Nicaise, Mensah Charles, Dakum Patrick. Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004-2017).. AIDS research and therapy. 2019. DOI: 10.1186/s12981-019-0241-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.